Implantable cardioverter defibrillators vs beta‐blocker
Adverse events · people with cardiac channelopathies
Implantable cardioverter defibrillators showed no clear difference in adverse events compared with β‐blocker therapy (low certainty).
1 finding from 1 review
- Implantable defibrillators versus medical therapy for cardiac channelopathies 2015 · Cochrane Headline outcomes onlyRR 2.44 [0.92, 6.44]2 studies · 86 participantsLow